Group 6 Copy 228
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    Does fracking contaminate water with hormone disrupting chemicals?

    One of the greatest joys for those who want to start a family is to be pregnant and have a healthy...

    Does the Experience of Awe Predict Ketamine's Rapid Antidepressant Effect?

    Ketamine is a very rapidly-acting and safe antidepressant medication given as an intravenous infusion, during...

    Backer Badge Funded